News and Publications

News:

What Dr. Yang advises about the latest Covid-19 variants:

New Covid Variants Are Circulating. Here’s What to Know.(Link is external)

Dr. Yang is called on by the HuffPost to clarify the importance of a second booster and the role of T cells in protecting against the new COVID variant. 

https://apple.news/AmEvCJ2uSQLqh9UeBSUXUUA(Link is external) (Link opens in new window)

Dr. Yang contributes his expertise to the New York Times about the differences between Omicron and previous Covid-19 strains.

What Are the Symptoms of Omicron?(Link is external) (Link opens in new window)

Dr. Yang's SARS-CoV-2 work is highlighted in the fall 2021 edition of "U" Magazine:

COVID Watchdog - U Magazine - UCLA Health - Los Angeles, CA(Link is external) (Link opens in new window)

Dr. Yang discusses what is known about COVID-19 antibodies and T cell protection immunity against infection with Dr. Mark Hellerstein, a professor in the Department of Nutritional Sciences and Toxicology at UC Berkeley and at the Department of Medicine at UC San Francisco and Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times.  Dr. Soon-Shiong is also a surgeon and scientist who has spent his career studying the human immune system in fighting cancer and infectious disease. Last year, Soon-Shiong’s company, ImmunityBio, received permission from the Food and Drug Administration to begin Phase 1 trials of its COVID-19 vaccine candidate.

Will the current crop of COVID vaccines provide lifetime immunity?(Link is external) (Link opens in new window)

Dr. Yang contributes an opinion piece to USA Today about SARS-CoV-2 variants, the efficacy of the vaccines against the variants, and the role of the media addressing the benefits of COVID-19 vaccines.

Forget about the frenzy over COVID-19 variants, viral evolution is normal(Link is external) (Link opens in new window)

Listen to Dr. Yang's interview by Gwyneth Paltrow on the Goop Podcast here:

Gwyneth Paltrow x Otto Yang: COVID-19 Antibodies, Vaccines, and Cutting-Edge Research | Goop(Link is external) (Link opens in new window)

See Dr. Yang’s recent COVID-19 work profiled by the Chan Zuckerberg Initiative here:

https://www.facebook.com/watch/?v=1508570472635173(Link is external) (Link opens in new window)

Recent Scientific Publications:

Evaluating the T cells that cause rejection of a transplanted hand:

https://journals.lww.com/transplantjournal/Fulltext/2021/07000/Longitudinal_Analysis_of_the_T_cell_Receptor.16.aspx(Link is external) (Link opens in new window)

Harnessing blood stem cells for immune gene therapies:

https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009404(Link is external) (Link opens in new window)

New artificial T cell receptors for treating cytomegalovirus in immunocompromised persons:

https://academic.oup.com/jid/article/222/5/853/5819787?login=true(Link is external) (Link opens in new window)

Rapidly waning antibodies against SARS-CoV-2 after COVID-19:

https://www.nejm.org/doi/10.1056/NEJMc2025179?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed(Link is external) (Link opens in new window)

Rapidly waning antibodies against SARS-CoV-2 after vaccination:

https://pubs.acs.org/doi/10.1021/acsnano.1c03972(Link is external) (Link opens in new window)

Antibody levels after prior COVID-19 plus vaccination:

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259703(Link is external) (Link opens in new window)

Ability of antibodies to react against SARS-CoV-2 variants after a combination of COVID-9 plus vaccination:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649753/(Link is external) (Link opens in new window)

T cell responses against SARS-CoV-2:

https://www.frontiersin.org/articles/10.3389/fimmu.2022.835830/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Immunology&id=835830(Link is external) (Link opens in new window)

Link to a full listing of Dr. Yang’s peer-reviewed scientific publications:

https://www.ncbi.nlm.nih.gov/myncbi/otto.yang.1/bibliography/public/(Link is external) (Link opens in new window)

Inquiries about the work of the Yang Immune Innovation Fund may be directed to Dr. Yang at: (310) 791-9491 or OYang@mednet.ucla.edu.

Inquiries about donating to the Immune Innovation Fund may be directed to Gretchen McGarry, Executive Director, UCLA Heath Science Development at (310) 794-4746 or GMcGarry@mednet.ucla.edu.

Your tax-deductible donation may also be made via this link: http://giving.ucla.edu/immune-innovation(Link is external) (Link opens in new window).

Thank you for your support of the Yang Immune Innovation Fund